NDTVCenter·
'Good Investment': Why Bank Of America Is Spending $250M A Year On GLP-1 Drugs
The rising demand for GLP-1 medications like Ozempic and Wegovy, which can cost thousands of dollars per patient each year, has weighed on the expenses of employers in the US.
Read at NDTV →
